Vitrolife completes the acquisition of Igenomix and carries out a non-cash consideration issue
On July 8, 2021, Vitrolife AB (publ) (“Vitrolife”) entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.[1] (“Igenomix”) from EQT and other shareholders (the “Transaction”). The conditions for the Transaction, including regulatory approvals such as merger control clearances, have been fulfilled and the acquisition of Igenomix is consequently completed. The Extraordinary General Meeting resolved on October 20, 2021 to approve the non-cash consideration issue in accordance with the Board’s proposal. The Extraordinary General Meeting revolved to issue in total